EXACT Therapeutics AS (OSL:EXTX)
Norway · Delayed Price · Currency is NOK 1.790
-0.010 (-0.56%)
At close: Oct 21, 2025
EXACT Therapeutics AS Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
12
Market Cap
139.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 4.46K | -450.06K | -99.02% |
| Dec 31, 2022 | 454.52K | 402.52K | 774.07% |
| Dec 31, 2021 | 52.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 628.08M |
| Nordhealth AS | 578.17M |
| Navamedic ASA | 523.56M |
| Photocure ASA | 522.86M |
| Omda AS | 458.96M |
| Vistin Pharma ASA | 452.25M |
| Gentian Diagnostics ASA | 163.38M |
| ArcticZymes Technologies ASA | 104.33M |